Tag Archive | "antibody"

Regeneron Pharmaceuticals : Right technology, right time

Tags: , ,

Regeneron Pharmaceuticals is Biopharmaceutical Company focusing on the development of human antibody technologies for the treatment of a number of different diseases.

Read the full story

Regeneron Pharmaceuticals: Partnering activity 2009-2014

Tags: , ,

Regeneron Pharmaceuticals announced around 18 partnering / licensing deals since 2009. Read the full story

Lilly forms a pharma deal for DuoBody antibodies

Tags: , , , ,

Genmab announced a pharma deal with Eli Lilly and Company to use and evaluate Genmab’s DuoBody technology platform for the creation of bispecific antibodies. Read the full story

Pharma partners, Menarini and Oxford Biotherapeutics, invest $1.1 billion in AML drug candidate

Tags: , , , ,

In October 2012, Pharma partners, Menarini and Oxford BioTherapeutics announce a strategic alliance to develop a portfolio of antibody-based drugs in the field of cancer. Read the full story

The Dealmakers Antibody Update

Tags: , ,

An update to the earlier article on therapeutic antibody deal making activity Read the full story

Mitsubishi Tanabe forms a second pharma deal with Covagen

Tags: , , , ,

Mitsubishi Tanabe Pharma and Covagen have entered into a pharma deal for a second target using FynomAb for $108.25 million. Read the full story

M&A news: MedImmune acquires Spirogen for $440 million

Tags: , ,

M&A news: MedImmune has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology for use in oncology Read the full story

Collaboration agreement for anti-IL-16 antibody in inflammatory diseases and ischaemic reperfusion injury

Tags: , ,

London, UK, 10 October 2013: MRC Technology, a technology transfer organisation, announced today it is collaborating with Boston University to develop an anti-IL-16 antibody for use in treatment of inflammatory diseases and Ischaemic Reperfusion Injury (IRI). The project is funded in part through a Biomedical Catalyst award of £577,000, granted to MRC Technology in 2012. Read the full story

Novo Nordisk in biotech licensing agreement with Adimab

Tags: , , , ,

Adimab announced its 3rd technology transfer, by biotech licensing the Adimab technology to Novo Nordisk, a big biotech company Read the full story

True North Therapeutics and iPierian in $30 million Series A financing round

Tags: , , ,

iPierian announced a Series A financing round of $30 million to advance iPierian’s drug development in neurodegenerative disease as well as launch a spin-out company, True North Therapeutics. Read the full story